132 related articles for article (PubMed ID: 36031722)
1. Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.
Walker H; Esbenshade AJ; Dale S; Bhatia K; Zhao Z; Babl FE; Conyers R; Haeusler GM
Pediatr Blood Cancer; 2022 Dec; 69(12):e29931. PubMed ID: 36031722
[TBL] [Abstract][Full Text] [Related]
2. Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.
Esbenshade AJ; Zhao Z; Baird A; Holmes EA; Dulek DE; Banerjee R; Friedman DL
J Clin Oncol; 2020 Sep; 38(27):3150-3160. PubMed ID: 32762614
[TBL] [Abstract][Full Text] [Related]
3. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
Zhao Z; Patel PA; Slatnick L; Sitthi-Amorn A; Bielamowicz KJ; Nunez FA; Walsh AM; Hess J; Rossoff J; Elgarten C; Myers R; Saab R; Basbous M; Mccormick M; Aftandilian C; Richards R; Nessle CN; Tribble AC; Sheth Bhutada JK; Coven SL; Runco D; Wilkes J; Gurunathan A; Guinipero T; Belsky JA; Lee K; Wong V; Malhotra M; Armstrong A; Jerkins LP; Cross SJ; Fisher L; Stein MT; Wu NL; Yi T; Orgel E; Haeusler GM; Wolf J; Demedis JM; Miller TP; Esbenshade AJ
J Clin Oncol; 2024 Mar; 42(7):832-841. PubMed ID: 38060973
[TBL] [Abstract][Full Text] [Related]
4. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
5. Low-risk febrile neutropenia in a medical oncology unit.
Leong DC; Kinlay S; Ackland S; Bonaventura A; Stewart JF
Aust N Z J Med; 1997 Aug; 27(4):403-7. PubMed ID: 9448881
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study.
Santschi M; Ammann RA; Agyeman PKA; Ansari M; Bodmer N; Brack E; Koenig C
PLoS One; 2023; 18(8):e0287233. PubMed ID: 37531403
[TBL] [Abstract][Full Text] [Related]
7. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
8. The outcome of febrile neutropenic episodes in paediatric oncology at the Wendy Fitzwilliam Paediatric Hospital.
Timothy M; Bodkyn C
West Indian Med J; 2011 Mar; 60(2):153-7. PubMed ID: 21942119
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
10. A clinical approach to non-neutropenic fever in children with cancer.
AlAzmi A; Jastaniah W; AlDabbagh M; Elimam N
J Oncol Pharm Pract; 2021 Apr; 27(3):560-569. PubMed ID: 32476589
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and Disposition of Oncology Patients With Non-neutropenic Fever and Positive Blood Cultures.
Sharma A; Sitthi-Amorn J; Gavigan P; Wolf J; Agulnik A; Brenner A; Li Y; Johnson LM
J Pediatr Hematol Oncol; 2021 Mar; 43(2):47-51. PubMed ID: 32604334
[TBL] [Abstract][Full Text] [Related]
12. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
[TBL] [Abstract][Full Text] [Related]
13. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
14. Nonneutropenic fever in children with cancer: A scoping review of management and outcome.
Allaway Z; Phillips RS; Thursky KA; Haeusler GM
Pediatr Blood Cancer; 2019 Jun; 66(6):e27634. PubMed ID: 30724005
[TBL] [Abstract][Full Text] [Related]
15. Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.
Haeusler GM; Thursky KA; Mechinaud F; Babl FE; De Abreu Lourenco R; Slavin MA; Phillips R
Br J Cancer; 2017 Jul; 117(2):171-178. PubMed ID: 28609435
[TBL] [Abstract][Full Text] [Related]
16. Fever and neutropenia in children with malignant disease.
Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
19. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
[TBL] [Abstract][Full Text] [Related]
20. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
